Bicycle Therapeutics plc Foreign Currency Transaction Gain (Loss), Realized
Bicycle Therapeutics plc (BCYC) reported Foreign Currency Transaction Gain (Loss), Realized of $400.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2022-03-01
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for the quarter ending 2020-12-31 was -$100.00K, a 107.69% decline year-over-year.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for the quarter ending 2020-09-30 was -$700.00K.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for the quarter ending 2020-06-30 was $100.00K, a 85.71% decline year-over-year.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for the quarter ending 2020-03-31 was $1.30M.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for fiscal 2021 was $400.00K, a 33.33% decline from fiscal 2020.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for fiscal 2020 was $600.00K, a 33.33% decline from fiscal 2019.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for fiscal 2019 was $900.00K, a 200.00% increase from fiscal 2018.
- Bicycle Therapeutics plc foreign currency transaction gain (loss), realized for fiscal 2018 was $300.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Realized 3 month | Foreign Currency Transaction Gain (Loss), Realized 6 month | Foreign Currency Transaction Gain (Loss), Realized 9 month | Foreign Currency Transaction Gain (Loss), Realized 12 month |
|---|---|---|---|---|
| 2021-12-31 | $400.00K 10-K · filed 2022-03-01 | |||
| 2020-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$800.00K derived: sum of 2 quarters · filed 2022-03-01 | -$700.00K derived: sum of 3 quarters · filed 2022-03-01 | $600.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | -$700.00K 10-Q · filed 2020-11-05 | -$600.00K derived: sum of 2 quarters · filed 2020-11-05 | $700.00K 10-Q · filed 2020-11-05 | $2.00M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $100.00K 10-Q · filed 2020-08-05 | $1.40M 10-Q · filed 2020-08-05 | $2.70M derived: sum of 3 quarters · filed 2022-03-01 | $1.90M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.30M 10-Q · filed 2020-05-07 | $2.60M derived: sum of 2 quarters · filed 2022-03-01 | $1.80M derived: sum of 3 quarters · filed 2022-03-01 | $2.50M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $500.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.20M derived: sum of 3 quarters · filed 2022-03-01 | $900.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$800.00K 10-Q · filed 2020-11-05 | -$100.00K derived: sum of 2 quarters · filed 2020-11-05 | -$400.00K 10-Q · filed 2020-11-05 | -$500.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $700.00K 10-Q · filed 2020-08-05 | $400.00K 10-Q · filed 2020-08-05 | $300.00K derived: sum of 3 quarters · filed 2021-03-11 | $341.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$300.00K 10-Q · filed 2020-05-07 | -$400.00K derived: sum of 2 quarters · filed 2021-03-11 | -$359.00K derived: sum of 3 quarters · filed 2021-03-11 | $41.00K derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$59.00K derived: sum of 2 quarters · filed 2021-03-11 | $341.00K derived: sum of 3 quarters · filed 2021-03-11 | $300.00K 10-K · filed 2021-03-11 |
| 2018-09-30 | $41.00K 10-Q · filed 2019-11-07 | $441.00K derived: sum of 2 quarters · filed 2019-11-07 | $400.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $400.00K 10-Q · filed 2019-08-08 | $200.00K 10-Q · filed 2019-08-08 | ||
| 2017-12-31 | -$600.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |